Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 11,703 shares at $50.54 ($592K) on 2020-11-06, disclosed to the SEC on 2020-11-10.
Open-market sale of $592k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.54 | 5,453 | $276K | 46.5% |
| 2 | $50.54 | 5,453 | $276K | 46.5% |
| 3 | $51.26 | 797 | $41K | 6.9% |
| Total | $50.59 avg | 11,703 | $592K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |